In 2014, revenue for the Pharmaceutical Manufacturing industry is expected to total $107.9 billion, up 12.5% from 2013. This represents an annualized growth rate of 15.7% since 2009. The industry's profitability has also been increasing – from 10.3% of industry revenue in 2008 to 10.9% in 2014. There are about 1,458 industry enterprises in 2014, employing about 641,163 people with a payroll of about $8.2 billion.
Hospitals are currently the main distribution channel for medicines produced by this industry. However, upcoming healthcare reforms will enable drugstores to become the major distribution channel in the near future.
The Pharmaceutical Manufacturing Industry in China is primarily engaged in the manufacture of chemical medicinal and pharmaceutical products in various formats, including ampoules, tablets, capsules, vials, ointments, powders, solutions, suspensions and radioactive medicine. These products are then sold via pharmacies or distributed via hospitals. Biological and veterinary medicine products are not included in this industry.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.